GlassScriptPhysician profile
Daryl P Pearlstein
NPI 1831118140
$172,916.30
in general payments reported to CMS, 2019-2025
32 companies · $6,622 in 2025
The $6,622 reported for 2025 was more than what 86% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92K · 2020: $11K · 2021: $25K · 2022: $15K · 2023: $11K · 2024: $12K · 2025: $6,622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Education: $10K · Travel and Lodging: $2,877 · Food and Beverage: $1,951 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,000.00 |
| Education | $10,000.00 |
| Travel and Lodging | $2,877.16 |
| Food and Beverage | $1,950.77 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $166,949.41 | 2019-2025 | Da Vinci Sp, Da Vinci Surgical System |
| Endogastric Solutions, INC | $3,244.64 | 2019-2024 | Esophyx |
| Csa Medical, INC | $457.54 | 2019 | |
| Surgical Theater. INC. | $390.65 | 2020-2021 | |
| Davol INC. | $277.10 | 2021-2022 | |
| Baxter Healthcare | $235.05 | 2021-2025 | Perclot, Tisseel, Floseal |
| Pulmonx Corporation | $186.55 | 2020-2024 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Covidien LP | $138.82 | 2019-2020 | |
| Atricure, INC. | $132.48 | 2022-2025 | Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System |
| Ethicon US, LLC | $114.02 | 2019-2025 | Surgicel Nu-Knit, Echelon Endopath, Stratafix |
| Caris Mpi, INC. | $109.76 | 2025 | Mi Cancer Seek |
| Merit Medical Systems INC | $92.36 | 2021-2024 | |
| Kls-Martin L.P. | $64.81 | 2019-2024 | |
| Allergan, INC. | $63.72 | 2021 | |
| Cook Medical LLC | $46.00 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $45.78 | 2021 | |
| Becton, Dickinson and Company | $39.10 | 2024 | Progel Applicator Spray Tips |
| Regeneron Healthcare Solutions, INC. | $33.86 | 2023 | Libtayo |
| Medela LLC | $30.50 | 2022 | |
| Abbvie INC. | $29.80 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.28 | 2024 | |
| Erbe USA INC | $25.00 | 2021 | |
| Novartis Pharmaceuticals Corporation | $24.93 | 2024 | |
| Medtronic, INC. | $22.60 | 2023 | Signia |
| Blueprint Medicines Corporation | $22.13 | 2021 | |
| Olympus America INC. | $21.65 | 2025 | Endoeye Flex Deflectable Videoscope |
| Smith+Nephew, INC. | $18.78 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $16.45 | 2022 | |
| Zimmer Biomet Holdings, INC. | $15.00 | 2019 | |
| Boston Scientific Corporation | $14.52 | 2019 | |
| Integra Lifesciences Corporation | $14.01 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Genentech USA, INC. | $14.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daryl Pearlstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.